Alpheus

Alpheus Medical

This company develops a non-invasive sonodynamic therapy platform using low-intensity ultrasound and tumor-localising drugs to treat patients with glioblastoma and other brain cancers.

Alceus

This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.

Alpha Tau Medical

This oncology company develops intratumoral alpha-emitting radiation therapy devices to treat patients with solid tumours.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Carthera

This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.

Exact Therapeutics

The company develops an ultrasound-mediated platform for delivering targeted therapies to patients with cancer, neurological conditions and infectious diseases.

Cereius

This company develops targeted radiopharmaceuticals and radiodiagnostics for cancer patients, focusing on the treatment of solid tumour brain metastases.

SonoThera™

This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.